Mineralys Eyes NDA As Lorundrostat Scores CKD Win In Race With AstraZeneca

Mineralys Is In A Close Race With AstraZeneca

 
• By Sushmita Panda
  
Mineralys Therapeutics
Mineralys Therapeutics (Shutterstock)

More from Clinical Trials

More from Therapy Areas